Umapati Pharmaceuticals Private Limited
About Umapati Pharmaceuticals Private Limited
Data last updated:
Umapati Pharmaceuticals Private Limited is a private limited company based in Muzaffrabad, Uttar Pradesh, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 29 November 2023.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U21003UP2023PTC193240.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kapil Kamboj and Dushyant Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Muzaffrabad, Uttar Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.12 Cr. For the same year it recorded a net loss of ₹5 (net margin 0%).
Company details
Contact details
Umapati Pharmaceuticals Private Limited's registered office is in Muzaffrabad, Uttar Pradesh.
- Registered AddressNear Hdfc Bank, Jp Market Arya Nagar, Muzaffrabad, Uttar Pradesh, India – 247662
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Umapati Pharmaceuticals Private Limited
FY 2025 filings availableUmapati Pharmaceuticals Private Limited reported revenue of ₹2.12 Cr for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹5 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | 0% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Umapati Pharmaceuticals Private Limited, buy the company report.
Board of directors of Umapati Pharmaceuticals Private Limited
Umapati Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kapil Kamboj | Director | 29 Nov 2023 | 2 Years 11 Months | Current |
| Dushyant Kumar | Director | 29 Nov 2023 | 2 Years 11 Months | Current |
Peer comparison
Umapati Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ajmera Pharmaceuticals Pvt Ltd | ₹2.15 Cr (FY 2025) | 3.0% | Indore, Madhya Pradesh, India | |||
| Granvalor Pharmaceuticals Private Limited | ₹2.14 Cr (FY 2025) | 22.0% | Hyderabad, Telangana, India | |||
| Tirupatimsshree Pharmaceuticals Private Limited | ₹2.13 Cr (FY 2025) | 2.0% | Noida, Uttar Pradesh, India | |||
| Humanize Pharmaceuticals Private Limited | ₹2.12 Cr (FY 2025) | 11.0% | Pimpri, Maharashtra, India | |||
| Ebc Pharmaceuticals Private Limited | ₹2.12 Cr (FY 2025) | 50.0% | Thrissur, Kerala, India | |||
| Umapati Pharmaceuticals Private Limitedthis company | ₹2.12 Cr (FY 2025) | -₹5 | 0% | Muzaffrabad, Uttar Pradesh, India | ||
| Dzire Pharmaceuticals Private Limited | ₹2.11 Cr (FY 2025) | 94.0% | Hisar, Haryana, India | |||
| Bioquest Pharmaceuticals Private Limited | ₹2.11 Cr (FY 2024) | 3.0% | New Delhi, Delhi, India | |||
| Genin Pharmaceuticals Private Limited | ₹2.11 Cr (FY 2018) | 364.0% | New Delhii, Delhi, India | |||
| Arizzer Pharmaceuticals Private Limited | ₹2.11 Cr (FY 2024) | 31.0% | Mumbai, Maharashtra, India | |||
| Dr Dubri Pharmaceuticals Private Limited | ₹2.11 Cr (FY 2021) | -31.0% | New Delhi, Delhi, India |
To see the full peer comparison of Umapati Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Umapati Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Umapati Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Umapati Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Umapati Pharmaceuticals Private Limited has 3 board changes on record since 2023: 2 appointments and 1 cessation. The latest: Charan Jeet Singh ceased to be Director on 19 Mar 2024.
Frequently asked questions
Umapati Pharmaceuticals is an active private limited company based in Muzaffrabad, Uttar Pradesh, India. The company works in paper and paper products, within the paper industry. It was incorporated on 29 November 2023 (3+ years old) and is registered under CIN U21003UP2023PTC193240.
Umapati Pharmaceuticals has 2 current directors:
- Kapil Kamboj - Director
- Dushyant Kumar - Director
The latest financial statements of Umapati Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Umapati Pharmaceuticals is U21003UP2023PTC193240. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Umapati Pharmaceuticals was incorporated on 29 November 2023, making it 3+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Umapati Pharmaceuticals by revenue are Ajmera Pharmaceuticals Pvt Ltd, Granvalor Pharmaceuticals Private Limited, Tirupatimsshree Pharmaceuticals Private Limited, Humanize Pharmaceuticals Private Limited, Ebc Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Charan Jeet Singh ceased to be Director on 19 Mar 2024. Dushyant Kumar was appointed as Director on 29 Nov 2023. Kapil Kamboj was appointed as Director on 29 Nov 2023.
The registered office of Umapati Pharmaceuticals is at Near Hdfc Bank, Jp Market Arya Nagar, Muzaffrabad, Uttar Pradesh, India – 247662.
Umapati Pharmaceuticals operates in the paper industry, in the paper and paper products segment.
Umapati Pharmaceuticals can be reached at its registered office: Near Hdfc Bank, Jp Market Arya Nagar, Muzaffrabad, Uttar Pradesh, India – 247662.
Umapati Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Kanpur.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
